CDKL5 deficiency disorder: clinical features, diagnosis, and management

H Leonard, J Downs, TA Benke, L Swanson… - The Lancet …, 2022 - thelancet.com
CDKL5 deficiency disorder (CDD) was first identified as a cause of human disease in 2004.
Although initially considered a variant of Rett syndrome, CDD is now recognised as an …

Cyclin-dependent kinase-like 5 deficiency disorder: clinical review

HE Olson, ST Demarest, EM Pestana-Knight… - Pediatric …, 2019 - Elsevier
Abstract Cyclin-dependent kinase-like 5 (CDKL5) deficiency disorder (CDD) is a
developmental encephalopathy caused by pathogenic variants in the gene CDKL5. This …

ILAE classification and definition of epilepsy syndromes with onset in neonates and infants: Position statement by the ILAE Task Force on Nosology and Definitions

SM Zuberi, E Wirrell, E Yozawitz, JM Wilmshurst… - …, 2022 - Wiley Online Library
Abstract The International League Against Epilepsy (ILAE) Task Force on Nosology and
Definitions proposes a classification and definition of epilepsy syndromes in the neonate …

Safety and efficacy of ganaxolone in patients with CDKL5 deficiency disorder: results from the double-blind phase of a randomised, placebo-controlled, phase 3 trial

EMP Knight, S Amin, N Bahi-Buisson… - The Lancet …, 2022 - thelancet.com
Background CDKL5 deficiency disorder (CDD) is a rare, X-linked, developmental and
epileptic encephalopathy characterised by severe global developmental impairment and …

Identification of an elaborate complex mediating postsynaptic inhibition

A Uezu, DJ Kanak, TWA Bradshaw, EJ Soderblom… - Science, 2016 - science.org
Inhibitory synapses dampen neuronal activity through postsynaptic hyperpolarization. The
composition of the inhibitory postsynapse and the mechanistic basis of its regulation …

Quantitative phosphoproteomic analysis of the molecular substrates of sleep need

Z Wang, J Ma, C Miyoshi, Y Li, M Sato, Y Ogawa, T Lou… - Nature, 2018 - nature.com
Sleep and wake have global effects on brain physiology, from molecular changes,,–and
neuronal activities to synaptic plasticity,,,–. Sleep–wake homeostasis is maintained by the …

Rett syndrome: a neurological disorder with metabolic components

SM Kyle, N Vashi, MJ Justice - Open biology, 2018 - royalsocietypublishing.org
Rett syndrome (RTT) is a neurological disorder caused by mutations in the X-linked gene
methyl-CpG-binding protein 2 (MECP2), a ubiquitously expressed transcriptional regulator …

Improving diagnosis and broadening the phenotypes in early-onset seizure and severe developmental delay disorders through gene panel analysis

N Trump, A McTague, H Brittain… - Journal of medical …, 2016 - jmg.bmj.com
Background We sought to investigate the diagnostic yield and mutation spectrum in
previously reported genes for early-onset epilepsy and disorders of severe developmental …

Clinical and biological progress over 50 years in Rett syndrome

H Leonard, S Cobb, J Downs - Nature Reviews Neurology, 2017 - nature.com
In the 50 years since Andreas Rett first described the syndrome that came to bear his name,
and is now known to be caused by a mutation in the methyl-CpG-binding protein 2 (MECP2) …

RettBASE: Rett syndrome database update

R Krishnaraj, G Ho, J Christodoulou - Human mutation, 2017 - Wiley Online Library
Rett syndrome (RTT) is an X‐linked progressive neurodevelopmental disorder that primarily
affects females. Mutations in the MECP2 gene have been attributed as the major genetic …